Qiagen was the second-best performer, with a weekly return of 16.92%. The 3-star stock has gained 10.76% over the last three ...

Nearly 230 million Americans are bracing for the storm, which is expected to impact regions stretching over 2,000 miles.

As of Friday morning, some school districts and the Austin Community College have cancelled weekend activities ahead of the winter storm hitting Central Texas.

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

Is Europe raising its drug prices? Depends who you ask; ImmunityBio rally burns short-sellers; Elizabeth Holmes asks Trump for early release from prison.

Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table encapsulates their recent ratings, offering a ...

Abbott issued disaster declarations Thursday for more than 130 counties ahead of a winter freeze expected to sweep into Texas ...

Abbott Laboratories reported fourth quarter sales below expectations before the market opened on Jan. 22, sending the stock down nearly 12% from the prior day's closing. The biggest hits came from ...

Texas Gov. Greg Abbott issues disaster declaration for 134 counties as a winter storm nears; ERCOT says electric grid is capable of handling power demand.

Abbott reports fourth-quarter sales that miss analysts’ estimates.